Fairness opinions › Acquirers
Becton Dickinson: healthcare acquisitions with fairness opinions
2 public-company targets, 2014-2017, $38B combined enterprise value. The multiples Becton Dickinson paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
16.6x
Median EV / revenue paid
4.80x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2017-04-23 | C. R. Bard | Becton Dickinson | Medical Devices and Supplies | $25B | 20.1x | 6.47x | 6.0%–7.0% | Goldman Sachs |
| 2014-10-05 | CareFusion | Becton Dickinson | Medical Devices and Supplies | $13B | 13.0x | 3.14x | 8.0%–9.0% | Perella Weinberg Partners |